SAHPRA commits adequate required resources for implementing, maintaining and continually improving the quality management system to achieve objectives.
Cannabis and related substances
The South African Health Products Authority (SAHPRA) is the regulatory authority of South Africa responsible for the regulation of health products intended for human and animal use.
Fees payable in terms of the provisions of the medicines and related substances act, 1965
The annual report has been prepared in accordance with the guidelines on the annual report as issued by the National Treasury.
This was the first meeting to discuss the topic of increasing competencies in regulatory science in the African region.
Cannabis and related substances.
A library of all SAHPRA related guidelines
The SAHPRA Strategic Plan for the new five-year cycle, 2020 – 2025 and the Annual Performance Plan for the 2021 – 2022 medium-term period.
The Government Gazette is used by the government as an official way of communicating to the general public.
Bid’s and quotations issued.
These guidelines contain the reference material and rules you will need to successfully and consistently implement and maintain the SAPHPRA master-brand across a broad range of applications.
Notification of registration of medicines in terms of Section 17 of the Medicines and Related Substances Act, 1965 (Act 101 of 1965)